Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FD4YV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,569
Award facts
- Contract value 100% obligated
- $18,568.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,568.80 by the Defense Logistics Agency (DLA) on September 26, 2025. The contract covers the supply of Xolair 150 mg/ml syringes, a biologic medication commonly used for treating moderate to severe allergic asthma and chronic idiopathic urticaria. Performance will be completed by October 20, 2025, with work conducted at the contractor's Park Ridge facility. This award was issued without a set-aside designation, allowing the contractor to compete on an equal basis with other vendors.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a ceiling value of $499,999,999 and extends through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent contract performance, leveraging its woman-owned small business status and extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables for military health systems.
Quick answers
Who was awarded contract SPE2DB25FD4YV?
SPE2DB25FD4YV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FD4YV worth?
The government has obligated $18,569 on SPE2DB25FD4YV.
Is contract SPE2DB25FD4YV an order under another contract?
Yes. SPE2DB25FD4YV is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB25FD4YV competed?
The extent of competition for SPE2DB25FD4YV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award